NASDAQ: AIHAesthetic Medical International Holdings Group Ltd Stock
$0.47+0.01 (+2.17%)
Updated Apr 25, 2024
AIH Price
$0.47
Fair Value Price
N/A
Market Cap
$22.44M
52 Week Low
$0.29
52 Week High
$1.43
P/E
-4.05x
P/B
3.32x
P/S
0.23x
PEG
N/A
Dividend Yield
N/A
Revenue
$94.41M
Earnings
-$5.28M
Gross Margin
47.2%
Operating Margin
-5.58%
Profit Margin
-5.5%
Debt to Equity
10.78
Operating Cash Flow
$10M
Beta
0.42
Next Earnings
May 14, 2024
Ex-Dividend
N/A
Next Dividend
N/A
AIH Overview
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 15 treatment centers in China, Hong Kong, and Singapore. Aesthetic Medical International Holdings Group Limited was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AIH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AIH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AIH is good value based on its book value relative to its share price (3.32x), compared to the US Medical Care Facilities industry average (4.54x)
P/B vs Industry Valuation
AIH is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more AIH due diligence checks available for Premium users.
Be the first to know about important AIH news, forecast changes, insider trades & much more!
AIH News
Valuation
AIH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-4.05x
Industry
-0.78x
Market
40.97x
AIH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.32x
Industry
4.54x
AIH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AIH's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
AIH's Earnings (EBIT) of -$5.27M... subscribe to Premium to read more.
Interest Coverage Financials
AIH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$79.1M
Liabilities
$74.3M
Debt to equity
10.78
AIH's short-term liabilities ($56.90M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AIH's long-term liabilities ($16.00M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AIH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AIH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
AIH's operating cash flow ($10.28M)... subscribe to Premium to read more.
Debt Coverage Financials
AIH vs Medical Care Facility Stocks
Aesthetic Medical International Holdings Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.